0455.HKライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (26 4月 2024 @ 14:14):

Stats
本日の出来高	4 000.00
平均出来高	388 433
時価総額	569.76M
EPS	HKD0 ( 2023-08-28 )
Last Dividend	HKD0.00260 ( 2023-06-29 )
Next Dividend	HKD0 ( N/A )
P/E	-26.50
ATR14	HKD0 (0.00%)

Tianda Pharmaceuticals 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Tianda Pharmaceuticals 財務諸表

Annual	2023
収益:	HKD532.09M
総利益:	HKD255.53M (48.02 %)
EPS:	HKD-0.0112

FY	2023
収益:	HKD532.09M
総利益:	HKD255.53M (48.02 %)
EPS:	HKD-0.0112

FY	2022
収益:	HKD546.69M
総利益:	HKD251.52M (46.01 %)
EPS:	HKD-0.0254

FY	2022
収益:	HKD509.96M
総利益:	HKD241.22M (47.30 %)
EPS:	HKD-0.0101

Financial Reports:

No articles found.

Tianda Pharmaceuticals Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0.0112 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0.00260 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

Tianda Pharmaceuticals Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 4.25 - low (41.27%) | Divividend Growth Potential Score: 0 - No dividend expected

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	HKD0.00450	2010-07-23
Last Dividend	HKD0.00260	2023-06-29
Next Dividend	HKD0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	14	--
Total Paid Out	HKD0.0530	--
Avg. Dividend % Per Year	0.00%	--
Score	1.23	--
Div. Sustainability Score	4.25
Div.Growth Potential Score	0
Div. Directional Score	1.955	--

Next Divdend (Est)
(2024-05-07)

HKD0.00229 Estimate 3.07 %

Dividend Stability

0.25 Very Poor

Dividend Score

1.23

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
3939.HK	Ex Dividend Junior	2023-06-07	Annually	0.00%
1776.HK	Ex Dividend Junior	2023-07-11	Annually	0.00%
0817.HK	Ex Dividend Junior	2023-09-18	Semi-Annually	0.00%
2359.HK	Ex Dividend Knight	2023-06-05	Annually	0.00%
1345.HK	Ex Dividend Junior	2023-10-04	Semi-Annually	0.00%
0390.HK	Ex Dividend Junior	2023-07-19	Annually	0.00%
6626.HK	Ex Dividend Knight	2023-09-04	Annually	0.00%
1897.HK	Ex Dividend Knight	2023-07-05	Semi-Annually	0.00%
0921.HK	Ex Dividend Junior	2023-07-10	Sporadic	0.00%
0052.HK	Ex Dividend Knight	2023-09-12	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.0454	1.500	-0.908	-1.362	[0 - 0.5]
returnOnAssetsTTM	-0.0263	1.200	-0.878	-1.053	[0 - 0.3]
returnOnEquityTTM	-0.0405	1.500	-1.561	-2.34	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	1.099	0.800	9.51	7.61	[1 - 3]
quickRatioTTM	0.854	0.800	9.68	7.75	[0.8 - 2.5]
cashRatioTTM	0.518	1.500	8.23	10.00	[0.2 - 2]
debtRatioTTM	0.120	-1.500	7.99	-10.00	[0 - 0.6]
interestCoverageTTM	-5.45	1.000	-3.13	-3.13	[3 - 30]
operatingCashFlowPerShareTTM	-0.0241	2.00	-0.00802	-0.0160	[0 - 30]
freeCashFlowPerShareTTM	-0.0424	2.00	-0.0212	-0.0424	[0 - 20]
debtEquityRatioTTM	0.187	-1.500	9.25	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.480	1.000	5.33	5.33	[0.2 - 0.8]
operatingProfitMarginTTM	-0.0545	1.000	-3.09	-3.09	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-0.468	1.000	-3.71	-3.71	[0.2 - 2]
assetTurnoverTTM	0.580	0.800	9.47	7.57	[0.5 - 2]
Total Score				4.25

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-23.59	1.000	-2.48	0	[1 - 100]
returnOnEquityTTM	-0.0405	2.50	-1.003	-2.34	[0.1 - 1.5]
freeCashFlowPerShareTTM	-0.0424	2.00	-0.0141	-0.0424	[0 - 30]
dividendYielPercentageTTM	0.981	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-0.0241	2.00	-0.00802	-0.0160	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.156	1.500	-2.30	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-0.0972	1.000	-4.93	0	[0.1 - 0.5]
Total Score				-0.341

Tianda Pharmaceuticals

Tianda Pharmaceuticals Limited, an investment holding company, engages in the research and development, production, and sale of pharmaceutical, biotechnology, and healthcare products in Mainland China, Hong Kong, and Australia. Its product range includes Chinese medicines, chemical drugs, biological and health products, and medical appliances covering the area of cardio-cerebrovascular, pediatric, anti-flu and respiratory, anti-infection, detoxification, urological agents, and others. The company offers its health products under the Herb Valley and Tuokang brands. It also engages in the sale and wholesale of Chinese herbal medicines, traditional Chinese medicine decoction pieces and Chinese medicines; provision of Chinese medical services; and trading of agricultural by-products. The company was formerly known as Tianda Holdings Limited and changed its name to Tianda Pharmaceuticals Limited in September 2012. The company was incorporated in 1992 and is headquartered in Central, Hong Kong. Tianda Pharmaceuticals Limited is a subsidiary of Tianda Group Limited.